Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional

Copper Cu 64 PSMA I&T PET Imaging in Men With Suspected Recurrence of Prostate Cancer

ClinicalTrials.gov ID: NCT06235099

Public ClinicalTrials.gov record NCT06235099. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 26, 2026, 12:18 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3, Multi-Center, Open-label Study to Test the Diagnostic Performance of Copper Cu 64 PSMA I&T PET/CT in Men With Biochemical Recurrence of Prostate Cancer

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This is a prospective, open-label Phase 3 study to evaluate copper Cu 64 PSMA I\&T injection for PET/CT imaging in patients with recurrent prostate cancer after radical prostatectomy or radiation therapy.

Study identification

NCT ID
NCT06235099
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Curium US LLC
Industry
Enrollment
235 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
Male
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 1, 2024 (Actual)
Primary completion
Feb 18, 2025 (Actual)
Completion
Feb 18, 2025 (Actual)
Last update posted
Feb 18, 2026

2024 – 2025

United States locations

U.S. sites
31
U.S. states
16
U.S. cities
27
Facility City State ZIP Site status
Providence Medical Foundation Fullerton California 92835 —
Tower Urology Los Angeles California 90048 —
VA Greater Los Angeles Healthcare System Los Angeles California 90073 —
Hoag Memorial Hospital Presbyterian Newport Beach California 92663 —
University of California, Irvine Orange California 92868 —
San Francisco VA Medical Center San Francisco California 94121 —
Providence Saint John's Health Center Santa Monica California 90404 —
Stanford Hospital & Clinics Stanford California 94305 —
Georgetown University Medical Center Washington D.C. District of Columbia 20007 —
University of Miami Miller School of Medicine Miami Florida 33136 —
Biogenix Molecular, LLC Miami Florida 33165 —
Florida Urology Partners Tampa Florida 33615 —
Edward Hines Jr VA Hospital Hines Illinois 60141 —
Urology of Indiana, LLC Carmel Indiana 46032 —
Indiana University Health Neuroscience Center Indianapolis Indiana 46202 —
University of Iowa Iowa City Iowa 52242 —
The University of Kansas Hospital Kansas City Kansas 66160 —
M Health Fairview University of Minnesota Medical Center Minneapolis Minnesota 55455 —
SSM Health Saint Louis University Hospital St Louis Missouri 63104 —
John Cochran VA Medical Center St Louis Missouri 63106 —
Washington University School of Medicine St Louis Missouri 63110 —
Great Plains Health, Diagnostic Imaging North Platte Nebraska 69101 —
XCancer Omaha Nebraska 68130 —
Queens Hospital Center Jamaica New York 11432 —
James J. Peters VA Medical Center The Bronx New York 10468 —
Cleveland Clinic Cleveland Ohio 44195 —
VA Portland Health Care System Portland Oregon 97239 —
Carolina Urologic Research Center, LLC Myrtle Beach South Carolina 29572 —
University of Tennessee Medical Center Knoxville Tennessee 37920 —
Excel Diagnostics and Nuclear Oncology Center Houston Texas 77042 —
Urology San Antonio San Antonio Texas 78229 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT06235099, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Feb 18, 2026 · Synced Oct 26, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT06235099 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →